Peter McNamara, Chief Scientific Officer at Tectonic Therapeutic, Inc. (TECX), sold 43 shares at $35.00 ($2K) on 2026-08-12, disclosed to the SEC on 2026-08-14.
Scheduled sale ($2k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TECX | SELL | 2026-07-01 | $6K | — | Filing → |
| TECX | SELL | 2026-03-09 | $189K | — | Filing → |
| TECX | SELL | 2026-03-05 | $78K | — | Filing → |